Comparison of Ticagrelor Versus Clopidogrel on Residual Thrombus Burden During Percutaneous Coronary Intervention: an Optical Coherence Tomography Study
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 22 Dec 2016
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Acute coronary syndromes; Coronary artery disease; Embolism and thrombosis
- Focus Therapeutic Use
- 19 Dec 2016 Status changed from discontinued to withdrawn prior to enrolment.
- 27 Jun 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 30 Jan 2014 According to ClinicalTrials.gov record planned end date changed from 1 Aug 2014 to 1 Dec 2014.